Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Sofosbuvir plus ribavirin combination regimen boost liver functions and antioxidant profile in hepatitis C virus patients.

Microbial pathogenesis - 1 Jan 2021

Ragab AboZaid Omayma A, Mahfouz Mohamed K, Abdel Hammed Omneia M, Maksoud H A Abdel, Elwan Ali W, Abdallah Omneia Elsaid, Elharrif Mohamed G

Abstract excerpt

Hepatitis C virus is an infectious pathogen affecting thousands of people causing great damage to the liver and consider an important cause of morbidity and mortality in developing countries. This research was conducted on 30 patients infected with hepatitis C virus and 10 control normal volunteers after taking consent of them in order to evaluate the liver function and antioxidants profile after treatment with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antioxidants
Share to Antiviral Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Ribavirin

Share to Sofosbuvir

Share to Treatment Outcome

Source

Identifiers

PMID: 33460748
DOI: 10.1016/j.micpath.2021.104740

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Sofosbuvir plus ribavirin combination regimen boost liver functions and antioxidant profile in hepatitis C virus patients.PMID 33460748Read ↗

Effect of Silymarin as an Adjunct Therapy in Combination with Sofosbuvir and Ribavirin in Hepatitis C Patients: A Miniature Clinical Trial.Semantic proximity Read ↗

Impact of different sofosbuvir based treatment regimens on the biochemical profile of chronic hepatitis C genotype 4 patients.Semantic proximity Read ↗

The deleterious effects of sofosbuvir and ribavirin (antiviral drugs against hepatitis C virus) on different body systems in male albino rats regarding reproductive, hematological, biochemical, hepatic, and renal profiles and histopathological changes.Semantic proximity Read ↗

Oxidative Stress Response in Patients Infected by Diverse Hepatitis C Virus GenotypesSemantic proximity Read ↗

The Impact of Hepatitis C Virus Genotypes on Oxidative Stress Markers and Catalase Activity.Semantic proximity Read ↗

A decrease in hepatitis C virus RNA to undetectable levels in chronic hepatitis C patients after PegIFNα + RVB or sofosbuvir + NS5A inhibitor treatment is associated with decreased insulin resistance and persistent oxidative stress.Semantic proximity Read ↗

Effects of vitamin E on chronic hepatitis C genotype 3: a randomized, double-blind, placebo-controlled study.Semantic proximity Read ↗

Correlation between vitamin D levels and apoptosis in geriatric patients infected with hepatitis C virus genotype 4.Semantic proximity Read ↗

Hemoglobin Decrease with Iron Deficiency Induced by Daclatasvir plus Asunaprevir Combination Therapy for Chronic Hepatitis C Virus Genotype 1b.Semantic proximity Read ↗

Effect of a Locally Formulated Carrot–Ginger Micronutrient Supplement on Immunological and Liver Function Biomarkers among HIV Patients Receiving Antiretroviral Therapy in Kaduna State, NigeriaSemantic proximity Read ↗

[Oxidative stress in patients with chronic hepatitis B before and after interferon alpha-2b treatment].Semantic proximity Read ↗

Polymorphic differences in SOD-2 may influence HCV viral clearance.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.